A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma

By Ya-Chen Tina Shih  

PharmacoEconomics, Vol. 25, Iss. 7, 2007-01 ,pp. : 577-590

Adis International

Access to resources Recommend Favorite

Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial

By Ta-Chung Chao   Zyting Chu   Ling-Ming Tseng   Tzeon-Jye Chiou   Ruey-Kuen Hsieh   Wei-Shu Wang   Chueh-Chuan Yen   Muh-Hwa Yang   Liang-Tsai Hsiao   Jin-Hwang Liu   Po-Min Chen  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 171-177

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab Combination Therapy: For the First-Line Treatment of Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

By Dhillon Sohita  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 917-930

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of ACE Inhibitors as First-Line Antihypertensive Therapy

By Nordmann A.J.   Krahn M.   Logan A.G.   Naglie G.   Detsky A.S.  

PharmacoEconomics, Vol. 21, Iss. 8, 2003-01 ,pp. : 573-585

Adis International

Access to resources Recommend Favorite

Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer

By Hatoum Hind T   Crawford E David   Nielsen Sandy Kildegaard   Lin Swu-Jane   Marshall Dennis C  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 261-270

Informa Healthcare

Access to resources Recommend Favorite